BNP Paribas Financial Markets’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.46M Buy
102,239
+16,173
+19% +$1.02M ﹤0.01% 1267
2025
Q1
$4.56M Buy
86,066
+817
+1% +$43.3K ﹤0.01% 1302
2024
Q4
$4.77M Buy
85,249
+70,824
+491% +$3.96M ﹤0.01% 1246
2024
Q3
$756K Buy
14,425
+10,882
+307% +$570K ﹤0.01% 1965
2024
Q2
$145K Sell
3,543
-52,466
-94% -$2.15M ﹤0.01% 2527
2024
Q1
$2.43M Sell
56,009
-7,076
-11% -$307K ﹤0.01% 1418
2023
Q4
$2.9M Buy
63,085
+7,842
+14% +$360K ﹤0.01% 1218
2023
Q3
$1.27M Buy
55,243
+1,888
+4% +$43.3K ﹤0.01% 1598
2023
Q2
$880K Sell
53,355
-33,687
-39% -$555K ﹤0.01% 1729
2023
Q1
$1.55M Buy
87,042
+34,158
+65% +$609K ﹤0.01% 1496
2022
Q4
$1.54M Sell
52,884
-28,049
-35% -$817K ﹤0.01% 1365
2022
Q3
$1.98M Buy
80,933
+60,347
+293% +$1.48M ﹤0.01% 1436
2022
Q2
$85.4K Buy
20,586
+8,822
+75% +$36.6K ﹤0.01% 2769
2022
Q1
$136K Sell
11,764
-25,610
-69% -$295K ﹤0.01% 2704
2021
Q4
$373K Buy
37,374
+26,466
+243% +$264K ﹤0.01% 2531
2021
Q3
$142K Buy
10,908
+5,611
+106% +$73.3K ﹤0.01% 2570
2021
Q2
$104K Sell
5,297
-9,437
-64% -$185K ﹤0.01% 2440
2021
Q1
$313K Buy
14,734
+9,920
+206% +$211K ﹤0.01% 2286
2020
Q4
$143K Sell
4,814
-3,100
-39% -$92.2K ﹤0.01% 2400
2020
Q3
$171K Buy
7,914
+5,232
+195% +$113K ﹤0.01% 2230
2020
Q2
$59.8K Sell
2,682
-10,078
-79% -$225K ﹤0.01% 2343
2020
Q1
$194K Buy
12,760
+9,351
+274% +$142K ﹤0.01% 2284
2019
Q4
$78.3K Sell
3,409
-17
-0.5% -$390 ﹤0.01% 2751
2019
Q3
$74K Buy
3,426
+1,739
+103% +$37.5K ﹤0.01% 2651
2019
Q2
$37.1K Sell
1,687
-1,479
-47% -$32.5K ﹤0.01% 2993
2019
Q1
$86.8K Buy
3,166
+3,163
+105,433% +$86.7K ﹤0.01% 2626
2018
Q4
$81 Sell
3
-592
-99% -$16K ﹤0.01% 3532
2018
Q3
$17.4K Buy
595
+137
+30% +$4K ﹤0.01% 2802
2018
Q2
$14.3K Sell
458
-918
-67% -$28.7K ﹤0.01% 2983
2018
Q1
$27.4K Sell
1,376
-264
-16% -$5.25K ﹤0.01% 3252
2017
Q4
$47.7K Buy
+1,640
New +$47.7K ﹤0.01% 3023